Compare PAYS & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAYS | PRGO |
|---|---|---|
| Founded | 2001 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 780.3M | 2.0B |
| IPO Year | 2020 | 2013 |
| Metric | PAYS | PRGO |
|---|---|---|
| Price | $14.28 | $14.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $13.50 | ★ $16.50 |
| AVG Volume (30 Days) | 618.6K | ★ 2.4M |
| Earning Date | 11-11-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 7.86% |
| EPS Growth | ★ 85.71 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $24,120,434.00 | $800,000.00 |
| Revenue This Year | $39.77 | N/A |
| Revenue Next Year | $16.20 | $0.74 |
| P/E Ratio | $64.80 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.08 | $9.23 |
| 52 Week High | $14.43 | $22.65 |
| Indicator | PAYS | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 64.87 | 57.97 |
| Support Level | $12.08 | $13.37 |
| Resistance Level | $14.43 | $15.06 |
| Average True Range (ATR) | 0.58 | 0.61 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 100.00 | 62.60 |
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The The company generates revenues from pharma card programs through card program management fees, transaction claim processing fees, interchange fees, customer service fees, other billable service fees and settlement income and other revenues are generated through cardholder fees, interchange fees, program management fees, load fees and breakage.
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.